because rigorously controlled human safety data specific to the TB-500 fragment does not exist, its longer-term risk profile, including possible immune reactions, remains unknown Evidence snapshot: Evidence for TB-500 itself is preclinical, drawn mainly from cell-culture and animal studies (a 1999 rat wound-healing study and later rodent cardiac- and tendon-injury models), with a 2026 scoping review describing the musculoskeletal literature on thymosin beta-4 and TB-500 as sparse and largely preclinical
If they form, they can hurt your cells
Wolverine Stack kit: the compounded BPC-157 plus TB-500 prescription, dispensed by a licensed pharmacy partner
It works by mimicking the GLP-1 hormone, which helps to reduce blood sugar levels and suppress appetite
In burn wound models, BPC-157-treated animals showed decreased inflammatory cell infiltration compared to controls

Research-grade specs Components: BPC-157 + TB-500 (equal amounts) 5 MG vial: BPC-157 5 mg + TB-500 5 mg (10 mg total) 10 MG vial: BPC-157 10 mg + TB-500 10 mg (20 mg total) Format: Lyophilized powder, single-vial blend Pathways studied: Cell migration and signalling (BPC-157), actin-binding (TB-500) Studied applications Comparative single-compound vs combined-mechanism research Cell migration and cytoskeletal pathway studies Peptide stability and reconstitution research Research replication of frequently cited two-peptide combinations Quality & trust 99% HPLC purity, third-party tested Mass spectrometry identity confirmation LAL endotoxin testing on every batch Batch-specific Certificate of Analysis included cGMP manufactured in Dallas, Texas (USA) USA same-day shipping (orders before 2pm CT M-F) Free domestic shipping on orders over $200 Storage & handling Store lyophilized vials refrigerated at 28C, protected from light and heat Reconstitute with bacteriostatic water